amiodarone has been researched along with Pulmonary Arterial Hypertension in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandorski, D | 1 |
| Bogossian, H | 1 |
| Ghofrani, A | 1 |
| Schmitt, J | 1 |
| Höltgen, R | 1 |
1 review available for amiodarone and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
[Tachycardia and pulmonary arterial hypertension].
Topics: Amiodarone; Atrial Fibrillation; Electric Countershock; Humans; Pulmonary Arterial Hypertension; Tac | 2020 |